← Back to headlines
Amivantamab Vaccine Shows Promising Results in Advanced Cancer Patients
An international trial across 11 countries has shown that the Amivantamab vaccine produced a strong response in 15 patients with advanced cancer that had not responded to previous treatments.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
